Scientific Advances in Thoracic Oncology 2016

Ross A. Soo, Emily C.A. Stone, K. Michael Cummings, James R. Jett, John K. Field, Harry J.M. Groen, James L. Mulshine, Yasushi Yatabe, Lukas Bubendorf, Sanja Dacic, Ramon Rami-Porta, Frank C. Detterbeck, Eric Lim, Hisao Asamura, Jessica Donington, Heather A. Wakelee, Yi Long Wu, Kristin Higgins, Suresh Senan, Benjamin SolomonDong Wan Kim, Melissa Johnson, James C.H. Yang, Lecia V. Sequist, Alice T. Shaw, Myung Ju Ahn, Daniel B. Costa, Jyoti D. Patel, Leora Horn, Scott Gettinger, Solange Peters, Murry W. Wynes, Corinne Faivre-Finn, Charles M. Rudin, Anne Tsao, Paul Baas, Ronan J. Kelly, Natasha B. Leighl, Giorgio V. Scagliotti, David R. Gandara, Fred R. Hirsch*, David R. Spigel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Abstract

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

Original languageEnglish (US)
Pages (from-to)1183-1209
Number of pages27
JournalJournal of Thoracic Oncology
Volume12
Issue number8
DOIs
StatePublished - Aug 2017

Keywords

  • Adjuvant therapy
  • Biomarkers
  • Cancer prevention
  • Immunotherapy
  • Malignant mesothelioma
  • Molecular diagnostics
  • NSCLC
  • Pathology
  • Radiotherapy
  • SCLC
  • Screening
  • Smoking cessation
  • Staging
  • Surgery
  • Targeted therapy
  • Value of therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Scientific Advances in Thoracic Oncology 2016'. Together they form a unique fingerprint.

Cite this